Background/aim: Results show that oxidative stress is a pathophysiologic factor for alopecia areata (AA); however, the markers usedcan be confounding.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Background/aim: Results show that oxidative stress is a pathophysiologic factor for alopecia areata (AA); however, the markers usedcan be confounding.
📊
Key Findings & Data:Thus, we aimed to investigate the role of oxidative stress in the pathogenesis of AA through an evaluation ofischemia-modified albumin (IMA); other markers of the oxidant/antioxidant system, such as SOD, CAT, GSH-ST, and MDA; andcontributing clinical risk factors.Materials and methods: The usefulness of IMA as a new marker for oxidative stress was compared with that of other markers andevaluated in patients with AA.Results: The mean serum level of IMA was of higher statistical significance in AA patients than in the control group (IMA: 0.57 ±0.01 vs. 0.52 ± 0.02 ΔABSU, P 1 site of involvement of disease, and increased severity of disease were correlated withincreased oxidation.
💡
Conclusion & Impact:IMA has great potential as a biomarker of oxidative stress in AA when compared to other studied biomarkers.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Background/aim: Results show that oxidative stress is a pathophysiologic factor for alopecia areata (AA); however, the markers usedcan be confounding. Thus, we aimed to investigate the role of oxidative stress in the pathogenesis of AA through an evaluation ofischemia-modified albumin (IMA); other markers of the oxidant/antioxidant system, such as SOD, CAT, GSH-ST, and MDA; andcontributing clinical risk factors.Materials and methods: The usefulness of IMA as a new marker for oxidative stress was compared with that of other markers andevaluated in patients with AA.Results: The mean serum level of IMA was of higher statistical significance in AA patients than in the control group (IMA: 0.57 ±0.01 vs. 0.52 ± 0.02 ΔABSU, P 1 site of involvement of disease, and increased severity of disease were correlated withincreased oxidation. Presence of AA, male sex, and severe disease were determined to be independent risk factors for antioxidant andoxidant systems. IMA has great potential as a biomarker of oxidative stress in AA when compared to other studied biomarkers.
🔖
Cite This Article
ATAŞ, H., GÖNÜL, M., ÖZTÜRK, Y., KAVUTÇU, M. (2022). Ischemic modified albumin as a new biomarker in predicting oxidative stress in alopecia areata. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 1, 129–138. https://ajindex.com/articles/611803
Rigopoulos D, Larios G, Katsambas A. Skin signs of systemic diseases. Clin Dermatol 2011; 29: 531-540
Franks AG, Jr. Skin manifestations of internal disease. Med Clin North Am 2009; 93: 1265-1282
Alkhalifah A. Alopecia areata update. Dermatol Clin 2013; 31: 93-108
Muller SA, Winkelmann RK. Alopecia areata. An evaluation of 736 patients. Arch Dermatol 1963; 88: 290-297
Karadag AS, Ertugrul DT, Bilgili SG, Takci Z, Tutal E, Yilmaz H. Insulin resistance is increased in alopecia areata patients. Cutan Ocul Toxicol 2013; 32: 102-106
Bakry OA, Elshazly RM, Shoeib MA, Gooda A. Oxidative stress in alopecia areata: a case-control study. Am J Clin Dermatol 2014; 15: 57-64
Prie BE, Voiculescu VM, Ionescu-Bozdog OB, Petrutescu B, Iosif L, Gaman LE, Clatici VG, Stoian I, Giurcaneanu C. Oxidative stress and alopecia areata. J Med Life 2015; 8: 43-46
Ozdemir M, Kiyici A, Balevi A, Mevlitoglu I, Peru C. Assessment of ischaemia-modified albumin level in patients with psoriasis. Clin Exp Dermatol 2012; 37: 610-614
Caglar GS, Oztas E, Karadag D, Pabuccu R, Demirtas S. Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance. Fertil Steril 2011; 95: 310-313
Ahmad A, Manjrekar P, Yadav C, Agarwal A, Srikantiah RM, Hegde A. Evaluation of ischemia-modified albumin, malondialdehyde, and advanced oxidative protein products as markers of vascular injury in diabetic nephropathy. Biomark Insights 2016; 11: 63-68
Aydin O, Ellidag HY, Eren E, Kurtulus F, Yaman A, Yilmaz N. Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis. Biochem Med (Zagreb) 2014; 24: 383- 389
Ellidag HY, Eren E, Aydin O, Akgol E, Yalcinkaya S, Sezer C, Yilmaz N. Ischemia modified albumin levels and oxidative stress in patients with bladder cancer. Asian Pac J Cancer Prev 2013; 14: 2759-2763
Reddy VS, Perugu B, Garg MK. Ischemia-modified albumin must be evaluated as an oxidative stress marker together with albumin and bilirubin in individuals with acute appendicitis. Clinics (Sao Paulo) 2015; 70: 531-532
Awadallah SM, Atoum MF, Nimer NA, Saleh SA. Ischemia modified albumin: an oxidative stress marker in betathalassemia major. Clin Chim Acta 2012; 413: 907-910
Kavak A, Baykal C, Ozarmagan G, Akar U. HLA in alopecia areata. Int J Dermatol 2000; 39: 589-592